News

Chiesi Farmaceutici S.p.A, an international, research-focused biopharmaceuticals and healthcare group, and Haisco Pharmaceutical Group Co. Ltd entered a licensing agreement to develop, manufacture, and commercialize outside China and adjacent territories (Hong Kong SAR, Macau SAR, and Taiwan District) HSK31858,...

Cryoport, Inc., a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences announced the expansion of its global supply chain...

The advancements in technology and the desire for minimally invasive surgeries have converged to propel the field of robotic urological surgeries to the forefront. As the healthcare landscape evolves, robotics' importance is becoming increasingly evident, particularly within the urological sphere....

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more than 20% between 2023 and 2030. This progress is driven, in part, by the increasing...

The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that have already been authorized in certain overseas territories. The changes made by NPRA go on...

Specialist Contract Development and Manufacturing Organisation (CDMO), Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and Advanced Therapeutic Medicinal Products (ATMP) biopharmaceuticals following a £1m plus investment. Fully approved by...

Market-leading commercialization platform, Inizio, has announced ‘Inizio Launch Elevate’, a connected suite of its best-in-class capabilities designed to accelerate and simplify product launches for global pharma and biotech companies. Inizio Launch Elevate combines deep market and patient insights, launch strategy...